Prm126 - A Comparison of Mixture Cure and Standard Parametric Modeling to Estimate Long-Term Survival for Small-Cell Lung Cancer in Patients Treated With Nivolumab After Progression

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2246
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV


Related search